Value Frameworks in Clinical Decision Making: The Impact of ICER on Healthcare Providers
Author(s)
Huey K, Fierro L
Rutgers University, Piscataway, NJ, USA
OBJECTIVES The primary objective of this study is to determine clinician familiarity with value frameworks and evaluate the impact of value frameworks on clinical decision making. METHODS An online survey was distributed via email to clinicians from February 2020 to June 2020. The survey consisted of three main components: clinician demographic information, clinician familiarity with value frameworks and an ICER report case study. Data was analyzed utilizing descriptive statistics. RESULTS Forty eight clinicians completed the demographics and value framework familiarity components of the survey. 41/48 clinicians completed the ICER report case study. Forty six pharmacists, 1 physician, and 1 nurse responded to the survey. 100% of the respondents reported practicing in the USA. 79.2% (38/48) indicated that they have been practicing less than 5 years. Clinicians had the most familiarity with the NCCN evidence blocks framework (n=23), followed by ICER reviews (n=10) and ASCO value framework (n=8). Nineteen respondents reported they were not familiar with any of the value frameworks listed. 65.9% (27/41) of those that completed the ICER case study reported understanding the ICER results. 26.8% (11/41) of respondents reported they did not understand the ICER results. The majority (63.4%; 26/41) of respondents stated ICER results were considered in clinical decision-making. CONCLUSIONS There was a low awareness of value frameworks among the majority of clinicians surveyed. The majority of respondents understood the ICER results and considered this information in clinical decision making.
Conference/Value in Health Info
2020-11, ISPOR Europe 2020, Milan, Italy
Value in Health, Volume 23, Issue S2 (December 2020)
Code
PDG49
Topic
Health Service Delivery & Process of Care, Health Technology Assessment
Topic Subcategory
Hospital and Clinical Practices, Prescribing Behavior, Value Frameworks & Dossier Format
Disease
Drugs